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Infection-related stillbirths
Robert L Goldenberg, Elizabeth M McClure, Sarah Saleem, Uma M Reddy
Infection is an important cause of stillbirths worldwide: in low-income and middle-income countries, 50% of 
stillbirths or more are probably caused by infection. By contrast, in high-income countries only 10–25% of stillbirths 
are caused by infection. Syphilis, where prevalent, causes most infectious stillbirths, and is the infection most 
amenable to screening and treatment. Ascending bacterial infection is a common cause of stillbirths, but prevention 
has proven elusive. Many viral infections cause stillbirths but aside from vaccination for common childhood diseases, 
we do not have a clear prevention strategy. Malaria, because of its high prevalence and extensive placental damage, 
accounts for large numbers of stillbirths. Intermittent malarial prophylaxis and insecticide-treated bednets should 
decrease stillbirths. Many infections borne by animals and vectors cause stillbirths, and these types of infections 
occur frequently in low-income countries. Research that better defi nes the relation between these infections and 
stillbirths, and develops strategies to reduce associated adverse outcomes, should play an important part in reduction 
of stillbirths in low-income countries.
Introduction
Stillbirth, defi ned as no sign of life in a neonate at 
delivery, is one of the most common adverse outcomes 
of pregnancy. 3·2 million stillbirths or more occur 
worldwide every year, with 98% or more in countries of 
low and middle income.1–3 In such countries, the rate of 
stillbirths is generally 20–40 per 1000 births, increasing 
to 100 per 1000 births in some areas, compared with 
3–5 per 1000 births in most high-income countries.1–3 
Maternal or fetal infections account for 50% of stillbirths 
or more in low-income and middle-income countries, 
but only 10–25% in high-income countries.4–6 In a review 
of stillbirth in countries of low and middle income, the 
population attributable fraction was greater than 50% 
for fi ve risk factors associated with stillbirth, of which 
two factors—syphilis and chorioamnionitis—were 
infection-related.7 Important non-infectious causes of 
stillbirth include congenital anomalies, placental 
insuffi  ciency, placental abruption, and asphyxia.8,9
The lower limits of gestational age (20–28 weeks) and 
birthweight (350–1000 g) that are used to defi ne stillbirth 
vary across geographical areas.3 Infection is more clearly 
associated with early (<28 weeks) compared with late 
stillbirth (≥28 weeks), and with reduced birthweight.5,6,10 
Consequently, studies that assess only late fetal deaths 
will miss the large contribution of infection to stillbirths.
For many reasons, the relation between infection and 
stillbirth is often unclear.5,6 Most importantly, infection is 
seldom apparent from the case history or physical 
examination of the mother or fetus. Histological assess-
ments of the placenta, placental cultures, and fetal 
autopsies could miss important infections. Additionally, 
even with evidence of infection, the precise reasons for 
specifi c stillbirths are often diffi  cult to establish. Neither 
positive serological tests nor organisms in the placenta or 
fetus prove causality.4–7,10 Furthermore, infection can initiate 
a chain of events leading to stillbirth, and its contribution 
to fetal death might not be appreciated (eg, rubella 
infections cause congenital anomalies). Which stillbirths 
are attributed to infection depends partly on the extent of 
the investigation and the classifi cation system used.11
In countries of low and middle income, placental 
histological examination, placental cultures, and fetal 
autopsies are usually unavailable. In high-income 
countries, such tests are generally available but are not 
done routinely. Since confi rmation of the infectious 
aetiology of stillbirth requires use of these techniques at 
a minimum, we believe that the contribution of infections 
to stillbirth is substantially underdiagnosed in settings of 
low, middle, and high income. Furthermore, if routine 
bacterial and viral cultures were supplanted by advanced 
molecular techniques, the apparent contribution of 
infection to stillbirth would probably rise still further. For 
example, in this Review we will discuss the coxsackie 
virus as a cause of unexplained stillbirths.12
Mechanisms
Infection can cause stillbirth by several mechanisms. 
Maternal infection might lead to systemic illness with 
the mother becoming severely ill (eg, severe infl uenza), 
and the fetus might die because of high maternal fever, 
respiratory distress, or other systemic reactions, without 
organisms transmitted to the placenta or fetus.13,14 
Alternatively, the placenta might be directly infected, 
resulting in reduced blood fl ow to the fetus (eg, malaria),15 
or the fetus might be directly infected with damage to a 
vital organ.16 If infection occurs early in gestation, the 
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Search strategy and selection criteria
We searched Medline, PubMed, and available Cochrane Reviews (January, 1990–July, 
2009) using specifi c search terms including “stillbirth”, “perinatal death”, and “fetal 
death”, and several terms for infection and specifi c organisms, for articles on infection 
and stillbirth. We included studies published in the past 20 years, but we did not exclude 
older studies that we deemed relevant. We reviewed all studies identifi ed by the search 
that were published in English, and we reviewed English language abstracts of papers 
that were published in other languages. We also selected appropriate articles from the 
reference lists of reviewed papers. We focused on sentinel studies addressing infections 
that had the potential to cause a substantial number of stillbirths worldwide, and were 
likely or potentially able to contribute to an important reduction in stillbirths through 
prevention, treatment programmes, and further research.
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fetus might not die immediately but development of a 
congenital anomaly could lead to fetal death at a later 
stage of pregnancy.17 Last, a maternal infection of the 
genital tract or elsewhere might precipitate preterm 
labour that the fetus is unable to tolerate.18
We identifi ed at least 40 organisms with suffi  cient 
evidence to be implicated as a cause of fetal death,6 
including many diff erent bacteria, viruses, parasites, and 
fungi. Although we will not examine every organism in 
this Review, we have drawn attention to those that are 
important numerically or those for which evidence 
suggests that further research could be benefi cial. Of 
note, many infectious causes of stillbirth are borne by 
animals or vectors (table 1).19,20
Bacterial infections
More than 130 diff erent bacteria might participate in 
intrauterine infections, and many of these have been 
associated with stillbirth.4,6 The types of organisms and 
the mechanisms by which they cause fetal death are 
similar across geographical areas. However, the pro-
portion of pregnancies aff ected by bacterial infection is 
much higher in countries of low and middle income 
than in those of high income.3,7 Bacterial infections 
leading to stillbirth can be divided into those that reach 
the fetal compartment through the placenta, and those 
that ascend from the vagina through the cervix. In 
transplacental infections (eg, syphilis), the placental villi 
often show evidence of infection and since the organisms 
enter the fetus through the umbilical vein, the liver is 
the organ most frequently infected.
Transplacental infections: syphilis and other spirochaetes
Of all potential infectious causes of stillbirth worldwide, 
syphilis stands out because the disease causes a large 
number of stillbirths but is highly preventable. Treponema 
pallidum is the spirochaete responsible for syphilis. 
Occurrence of infection in women of reproductive age 
varies from as high as 20% in some African populations 
to about 0·02% in high-income countries.21–25 Spirochaetes 
can cross the placenta and infect the fetus, with risk of 
fetal infection related to the stage of maternal syphilis. If 
the mother is infected but untreated, about 40% of fetuses 
will die in utero and another 30–40% will be born alive 
but have congenital syphilis. More than 1 million cases of 
congenital syphilis occur worldwide every year.26,27 The 
most common cause of fetal death seems to be placental 
infection with decreasing blood fl ow to the fetus, although 
direct fetal infection also has a role.28 Most studies report 
syphilis to have a relative risk of stillbirth of 2–5; however, 
in a Tanzanian study, the relative risk was 18 for women 
with active syphilis.29 In some areas of sub-Saharan Africa, 
25–50% of all stillbirths are associated with syphilis.24 
Syphilis also contributes to stillbirths in other areas of the 
world including Russia, Asia, and South America.30–32
Stillbirths due to syphilis should be easy to eliminate. 
Within a functioning health system, screening of pregnant 
women for syphilis is feasible, and once disease is 
diagnosed, treatment is easy and inexpensive. Women 
who have been treated for syphilis have a similar or slightly 
greater stillbirth risk than do women who are not 
infected.33,34 The reasons for the present failure to eliminate 
congenital syphilis, especially in sub-Saharan Africa, 
include poor access to prenatal care or use of such services, 
and failure to provide appropriate treatment for syphilis 
because of lack of resources, poorly functioning supply 
systems, and other priorities such as HIV screening and 
treatment. Consequently, point-of-care rapid testing and 
treatment could be the most cost-eff ective method to 
reduce adverse pregnancy outcomes associated with 
syphilis.35 Schmid and colleagues26,27 converted the fetal or 
neonatal consequences of maternal syphilis into disability-
adjusted life-years (DALYs). They suggested that when 
stillbirth was included, the cost to save 1 DALY was about 
US$10 and was 25 times less expensive than that for 
infants born to women infected with HIV.26,27 Based on 
these and other data, WHO has launched a programme to 
eliminate congenital syphilis worldwide.36
Several other spirochaetal diseases are associated with 
stillbirth. Lyme disease, a systemic illness caused by the 
tick-borne Borrelia burgdorferi, was fi rst associated with 
stillbirth in 1987.37 Small series of stillbirths associated with 
maternal Lyme disease have been reported, with most fetal 
deaths occurring in the midtrimester. Spirochaetes have 
been found in fetal liver, spleen, kidney, and brain. 
However, large-scale serological studies have shown that 
few stillbirths are associated with Lyme disease except in 
highly endemic areas.38 In Tanzania, more than 30% of 
adults are seropositive for B burgdorferi39 compared with 
Organism Reservoir
Vector-borne infections
Malaria Plasmodium falciparum Mosquito
Lyme disease Borrelia burgdorferi Tick
Relapsing fever Borrelia duttonnii Tick
Tick-borne relapsing fever Borrelia recurrentis Tick
African sleeping sickness Trypanosoma brucei Tsetse fl y
Chagas’ disease Trypanosoma cruzi Triatomine (kissing bug)
Dengue fever Dengue virus Mosquito
Tularaemia Francisella tularensis Tick or deerfl y, animal carcasses, 
contaminated food or water
Animal-borne infections
Listeriosis Listeria monocytogenes Domesticated animal products
Anthrax Bacillus anthracis Domesticated animals
Q fever Coxiella burnetti Domesticated animals
Brucellosis Brucella melitenses Domesticated animals
Leptospirosis Leptospira interrogans Dogs, livestock, wild animals
Toxoplasmosis Toxoplasma gondii Warm-blooded animals
Lymphocytic choriomeningitis Lymphocytic choriomeningitis virus House mouse
Ljungan virus Ljungan virus Wild rodents (bank voles)
Streptococcus porcinus Streptococcus porcinus Swine
Table 1: Maternal infections borne by vectors and animals and associated with stillbirth
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2% in the USA and Norway, but whether Lyme disease is 
an important cause of stillbirths in African settings is 
unknown. Another spirochaetal disease associated with 
adverse pregnancy outcomes, mainly in sub-Saharan 
Africa, is tick-borne relapsing fever, caused by Borrelia 
duttonii. Findings from one study showed perinatal 
mortality of 30%.40 In the Democratic Republic of the 
Congo, 6·4% of pregnant women admitted to a maternity 
ward had relapsing fever.41 As with Lyme disease, in most 
African settings the prevalence of tick-borne relapsing 
fever and its contribution to stillbirths is unknown.42,43
Other bacterial causes of transplacental infections
Listeria monocytogenes is another example of a 
haematogenously transmitted organism that causes fetal 
death.44 The mother acquires this infection by eating 
contaminated food such as unpasteurised soft cheese or 
undercooked meat. During bacteraemia, the organisms 
are transmitted to the placenta and can cause villous 
necrosis and microabscesses. The organisms can be 
transmitted to the fetus, and occurrence of stillbirth is 
attributed to both placental dysfunction and fetal infection. 
Transplacental infections have also been reported in 
association with maternal tularaemia, clostridia, anthrax, 
typhoid fever, brucellosis, Haemophilus infl uenzae, 
Pseudomonas pyocyanea, the plant bacterium Agrobacterium 
radiobacter, and Mycobacterium tuberculosis.6 Additionally, 
maternal cachexia associated with late diagnosis of 
tuberculosis and advanced disease seems to be a risk 
factor for stillbirth.45 Although tuberculosis is generally 
rare in pregnancy, occurrence is increasing in many 
locations, especially in sub-Saharan African countries 
where HIV is prevalent. Whether co-infection increases 
the risk of stillbirth compared with the risk from HIV 
alone is unclear.46
With the exception of syphilis, the occurrence of still-
births related to bacterial transplacental infection in 
countries of low and middle income is largely unstudied. 
How ever, because of high prevalence of maternal infec-
tious disease in such countries, transplacental infections 
with several bacterial species are probably frequent. 
Ascending bacterial infections
Organisms that ascend from the vagina into the uterus 
enter the amniotic fl uid either through intact 
choriodecidual membranes or after membrane rupture.47 
The most common organ infected is the fetal lung, 
associated with fetal breathing of contaminated amniotic 
fl uid. Consequently, a common autopsy fi nding in still-
births is pneumonitis. Whether the fetus is stillborn with 
pneumonitis or is born alive with pneumonia depends on 
factors such as organism virulence, the fetal response, and 
time between infection and delivery. Blackwell48 and 
Romero49 and their colleagues postulated that a preterm 
infection usually elicits a fetal infl ammatory response and 
ultimately preterm labour, but if the fetus cannot initiate 
an adequate infl ammatory response, the outcome will 
probably be stillbirth. Stillbirths before 28 weeks seem to 
be strongly associated with intrauterine bacterial infection, 
whereas later preterm stillbirths are less likely to be caused 
by such infection.5,10 Therefore, the apparent prevalence of 
this condition will depend on whether calculations include 
stillbirths occurring from 20 weeks onwards, or only those 
occurring at a later gestational age.
In virtually all studies investigating chorioamnionitis, 
the frequency of histological chorioamnionitis in 
stillbirths is at least several times greater than in controls; 
whether this fi nding implies causation is unknown.7,50,51 
The occurrence of histological chorioamnionitis in 
stillbirths has varied substantially between studies, but 
results of about half of studies showed presence of the 
disorder in 70% or more stillbirths.48 In an Australian 
study, Lahra and colleagues50 reported that 37% of all 
stillbirths were associated with histological chorio-
amnionitis. Moreover, very early preterm and post-term 
stillbirths had substantially increased rates of histological 
chorioamnionitis (fi gure 1).
In several autopsy studies, organisms such as group B 
streptococcus, Escherichia coli, and Klebsiella spp have 
been cultured from fetal heart blood, liver, lung, or 
brain.52–55 For example, E coli was identifi ed in 25% of 
samples from the heart blood of stillborn babies in 
Zimbabwe. Naeye and co-workers56 studied stillbirths in 
Ethiopia and compared these results with fi ndings from 
the US Collaborative Perinatal Study. The types of 
organisms associated with ascending infections were 
similar in Ethiopia and the USA, but the frequency of 
stillbirth associated with infection was several times 
greater in Ethiopia. The authors speculated that the 
diff erence was caused by increased exposure to infectious 
organisms and a decreased immune response resulting 
from widespread malnutrition in African populations.
Prevention of stillbirths associated with ascending 
bacterial infection in the presence of intact membranes 
has proven elusive. No strategies—including antibiotic 
prophylaxis—seem to prevent intrauterine infection or 
associated stillbirths,57 although antibiotic treatment 
targeting bacterial vaginosis could be benefi cial in some 
women.58 In women with preterm premature rupture of 
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Figure 1: Histological chorioamnionitis in stillborn babies by gestational age
Reproduced from Lahra and colleagues,50 with permission from Elsevier.
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membranes, prophylactic antibiotics reduce histological 
chorioamnionitis, but have not yet shown a similar 
reduction in occurrence of stillbirths.59
Viral infections
Although viruses clearly cause stillbirths, the overall 
nature of this relation is not well studied, especially in 
countries of low and middle income. The complexity and 
expense of culturing of most viruses, and the technical 
diffi  culty and expense associated with PCR for 
identifi cation of viral DNA or RNA have hampered 
research. Few of these tests are routinely available in 
high-income countries and almost never in countries of 
low or middle income. Consequently, the importance of 
maternal viral infection as a cause of stillbirth in most 
areas of the world is unknown.
Despite variations in data, many studies show a small 
and often insignifi cant increase in stillbirth associated 
with maternal HIV-1 infection.34,60,61 One meta-analysis, 
done before general use of antiretroviral treatments, sug-
gested a signifi cant increase by three times (odds ratio 
3·91, 95% CI 2·65–5·77).62 In women with HIV-1 infection, 
risk of stillbirth seems to increase as maternal HIV disease 
worsens and CD4 cell counts drop.60 Since the virus rarely 
crosses the placenta or infects the fetus until labour, this 
increase in stillbirths is probably not directly caused by 
fetal HIV-1 infection. Instead, the stillbirth risk is probably 
due to maternal comorbidities and overall poor maternal 
health status, especially in countries of low and middle 
income. However, since the prevalence of maternal 
HIV-1 infection reaches more than 20% in sub-Saharan 
countries, the contribution of maternal HIV-1 infection to 
stillbirths is probably important in such areas. Concerns 
that combination antiretroviral treatment might contri-
bute to an increase in stillbirth in women with HIV-1 
infection have not been realised.63
Maternal infections with common childhood viruses 
(rubella, measles, mumps, and chickenpox) have been 
implicated in stillbirths.64–69 Maternal rubella was associated 
with congenital cataracts by Gregg67 in 1941. Subsequently, 
other abnormalities such as major cardiac defects have 
been recorded, some of which result in stillbirth later in 
pregnancy. Rubella also infects the placenta, increasing 
the risk of stillbirth, and can seemingly do so without 
fetal spread.17 Rubella outbreaks are routinely reported 
from many low-income and middle-income countries; 
however, their contribution to stillbirths in such areas is 
unknown.68 Maternal infections with mumps and rubeola 
(measles) have both been implicated as causes of 
stillbirth,66 and both viruses have been isolated from fetal 
tissues. In Guinea-Bissau, occurrence of stillbirth 
increased by four to nine times if the mother was infected 
with measles during her pregnancy.69 Varicella 
(chickenpox) infections during pregnancy can cause 
maternal pneumonia, placing infected women at risk for 
death as well as stillbirth. The virus also occasionally 
crosses the placenta and attacks the fetus directly.65
Such fi ndings confi rm the association between 
maternal infection with common childhood viruses and 
increased risk of stillbirth. Because of widespread 
immunisation in high-income countries, maternal 
infection with these organisms is extremely rare and few 
stillbirths due to these infections are reported. However, 
with vaccination rates at 50% or less in many countries 
of low or middle income, stillbirths caused by such 
infections probably occur. Universal vaccination for 
childhood diseases should eliminate these stillbirths.
Historically, maternal infl uenza infection has been 
associated with increased maternal and fetal deaths, but 
little data is available from low-income and middle-income 
countries.70 In the 2003 epidemic, severe acute respiratory 
syndrome was shown to be associated with placental and 
fetal pathology, but the association with pregnancy outcome 
needs to be more clearly defi ned.71 Although reports of 
infl uenza A H1N1 (2009 pandemic) infections in pregnancy 
are few, maternal deaths and stillbirths associated with this 
infection have been recorded.72 The American College of 
Obstetricians and Gynecologists (ACOG) recommends 
immunisation for all women who will be pregnant during 
the infl uenza season.73 Infl uenza infections are common 
in low-income and middle-income countries, and since 
immunisation for these viruses rarely occurs, the potential 
for an increase in stillbirths associated with various types 
of infl uenza infection is strong.
Though the relation has not been studied in countries 
of low and middle income, in high-income countries, one 
of the best described relations of a virus with stillbirth is 
for parvovirus B19.74–78 Parvovirus causes the common 
child hood rash erythema infectiosum, and also causes 
aplastic anaemia in children with sickle cell disease. 
Parvovirus can cross the placenta and pre ferentially 
attacks erythro poietic tissue, causing severe fetal anaemia, 
non-immune hydrops, and fetal death.76,77 Parvovirus can 
also cause stillbirth by directly attacking fetal cardiac 
tissue, resulting in cardiac damage without associated 
hydrops. Previous parvo virus infection elicits an antibody 
response that protects against subsequent maternal and 
fetal infection. However, even with a new maternal 
parvovirus infection, the risk of stillbirth is small.78,79 In 
the USA, less than 1% of all stillbirths result from 
parvovirus infection.80 However, fi ndings of a study in 
Sweden that used PCR for viral DNA to confi rm parvovirus 
infection, showed that 15% of all stillbirths were attributed 
to parvovirus.77 In another Swedish study, 8% of stillbirths 
were caused by parvovirus, and similar rates have been 
reported in Germany.78,79
The enterovirus family includes enterovirus, 
echovirus, coxsackie virus, and polio, all of which can 
cross the placenta and cause fetal death. However, the 
overall eff ect of such viruses on stillbirths is unknown, 
especially in countries of low and middle income. In a 
detailed investigation of unexplained perinatal deaths, 
Nuovo and colleagues12 identifi ed coxsackie virus in 48% 
of cases. The authors emphasised that the histological 
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fi ndings in the placenta were often non-specifi c and 
underscored the need for molecular testing to defi ne 
this relation. In a study from Sweden, of 21 women with 
stillborn babies, 52% were infected with coxsackie virus 
compared with only 22% of the control group.81 
Echovirus and entero viruses have also been cultured 
from stillborn babies. In most studies, unless the virus 
was specifi cally sought at autopsy with advanced 
molecular techniques, an infectious cause of stillbirth 
would have been missed. Similarly, cytomegalovirus has 
rarely been sought in cases of stillbirth.82,83 Findings 
from an Australian study showed that 9% of blood 
samples taken from stillbirths by cardiac puncture and 
analysed by PCR were positive for cytomegalovirus.84 
Furthermore, Syridou and colleagues85 showed 
signifi cantly in creased concentration of cytomegalovirus 
from PCR in the placentas of stillbirths (16%) compared 
with controls (3%; p=0·047). Since cytomegalovirus is 
the most common cause of congenital infection, and 
because it can infect the fetus, leading to fetal-growth 
restriction and CNS damage, the relation between 
cytomegalovirus and stillbirth warrants further research. 
Hepatitis and herpes simplex infections have also been 
described as a cause of fetal death.86
Newly described viruses are also being associated with 
stillbirth. For example, Ljungan virus, a picornavirus of 
bank voles, was originally isolated in the Ljungan Valley 
in Sweden and has since been reported in Denmark and 
the USA. Infection with the virus was recorded in 40% of 
stillborn babies in a small study of pregnant women, but 
not in any tissues from normal pregnancies. The overall 
importance of this infection as a cause of stillbirth in any 
location is unknown.19
Protozoal infections
Several protozoal intrauterine infections have been 
described, of which malaria seems to have the strongest 
association with stillbirth.
Malaria
40% of births worldwide occur in areas in which malaria is 
endemic (fi gure 2); 30 million of these pregnancies occur 
yearly in Africa alone.88 Malaria is caused by four types of 
intracellular parasites (especially Plasmodium falciparum) 
transmitted by several mosquito species.89 Primiparous 
women who are infected with P falciparum, and especially 
those who have been previously unexposed to malaria, 
generally have the worst outcomes: maternal death, fetal-
growth restriction, preterm birth, and stillbirth.88–90
Pregnancy outcome is directly related to the extent of 
placental malaria, which occurs in 13–63% of maternal 
infections.15,91 Placental insuffi  ciency results from 
lymphocyte and macrophage accumulation, and 
thickening of the basement membrane, impeding blood 
fl ow through the placenta and restricting transport of 
oxygen and nutrients to the fetus. Severe maternal 
anaemia associated with malaria could also contribute to 
stillbirth. Malaria organisms can cross the placenta, 
causing congenital malaria, but the importance of these 
infections for stillbirth is not clear. Results from a review 
of studies, mostly from endemic areas, showed that 
placental malaria was associated with twice the risk of 
stillbirth (odds ratio 2·19, 95% CI 1·49–3·22).92
Newman and colleagues93 reported that an Ethiopian 
population newly infected with malaria had increased risk 
by seven times, and the population attributable fraction of 
malaria for stillbirth is 32% according to fi ndings from a 





Figure 2: Global distribution of infection with Plasmodium falciparum malaria
Reproduced from Hay and Snow,87 and licensed to the Malaria Atlas Project (http://www.map.ox.ac.uk). PfAPI=P falciparum annual parasite incidence per 1000 people 
per year. PfPR2–10=P falciparum parasite rate age-standardised to 2–10 years.
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Tanzanian study.94 Although most studies of malaria and 
stillbirth are from Africa, similar results have been 
recorded in other endemic areas.95 Since a large number of 
women live in endemic areas, of whom a high percentage 
have placental malaria and, consequently, double the risk 
of stillbirth, malaria is probably the most important 
preventable infectious cause of stillbirth in countries of 
low and middle income. Evidence suggests that intermit-
tent antimalarial prophylaxis and use of insecticide-treated 
bednets could reduce the risk of stillbirth and other adverse 
outcomes associated with malaria.96,97
Other protozoal infections
The parasite Toxoplasma gondii normally spends its 
lifecycle in animals, but can be transmitted to humans. 
Human infection, toxoplasmosis, is generally asymp tom-
atic or causes only mild disease, but has been identifi ed 
as a cause of stillbirth in case reports.98 The prevalence of 
toxoplasma antibodies is more than 80% for pregnant 
women in Nigeria, compared with 15% in the USA.99 In 
Zimbabwe, serological tests for toxoplasmosis were four 
times more common in mothers who had stillbirths than 
in the control group, and in Jordan, the presence of 
T gondii was signifi cantly higher in women with adverse 
pregnancy outcomes than in the control group (54% vs 
12%, p<0·02).100 However, the importance of T gondii as a 
cause of stillbirth in low-income and middle-income 
countries is unknown. Many other protozoal infections 
that are common in tropical regions—such as 
trypanosomiasis (African sleeping sickness transmitted 
by the tsetse fl y) and Chagas’ disease (caused by 
Trypanosoma cruzi in South and Central America)—have 
been associated with stillbirth,101,102 but the extent of the 
association is unknown.
Other infectious causes of stillbirths
Little research has been done on the relation between 
various fungal infections and stillbirth, but case reports 
indicate that candida infections cause stillbirth.6 Addition-
ally, fi ndings from an observational study in Sri Lanka 
showed signifi cant reductions in occurrence of still birth 
associated with anthelmintic treatment, implica ting worm 
infestations as a possible cause of stillbirth.103
Prevention of infection-related stillbirths
Low-income and middle-income countries
The infectious disease burden during pregnancy is 
extremely high in many countries, and the stillbirth rate 
is probably high as a consequence.7,56 Therefore, pro-
grammes that screen for and treat syphilis should 
substantially reduce stillbirths (table 2). Antibiotic 
treatment for women with syphilis seems to eff ectively 
reduce the stillbirth risk to almost that of women without 
infection.32 Reduction of maternal malaria infections in 
endemic areas should also reduce the stillbirth rate. 
Antimalarial strategies that have been assessed specifi cally 
for implementation during pregnancy95,96 include malaria 
prophylaxis, especially intermittent therapy, and use of 
insecticide-treated bednets. Although these strategies 
clearly reduce malaria and outcomes such as severe 
anaemia, most studies have not been powered to show 
improvements in rare outcomes such as stillbirth.
A reduction in bacterial intrauterine infections, if 




Establish burden of infectious causes of stillbirth in developing 
countries with molecular biological techniques
Proportions of stillbirths in developing countries that are associated 
with Lyme disease, relapsing fever, Chagas’ disease, parvovirus, 
enterovirus, and many other maternal infections are unknown
Chorioamnionitis Develop eff ective prevention and treatment strategies Chorioamnionitis is probably the most common cause of stillbirth 
worldwide, and research aimed at reduction of such infection is crucial
Viral infections Develop vaccines for viral causes of stillbirth (eg, parvovirus, 
coxsackie viruses A and B, cytomegalovirus), and test 
eff ectiveness for prevention of stillbirth
Elimination of these infections during pregnancy should reduce 
stillbirths and other adverse pregnancy outcomes
Bacterial 
infections 
Establish clean delivery practices, maternal vaginal antisepsis 
(eg, chlorhexidine), and nutrition supplementation
Eff ects of such strategies for reduction of stillbirth needs to be 
ascertained
Table 3: Research priorities for reduction of infection-related stillbirths
Intervention Rationale
Syphilis Screening and treatment Intervention is eff ective; scale-up strategies are needed, especially in areas of high prevalence
Malaria Chemoprophylaxis (directed or 
intermittent); insecticide-treated 
bednets against malaria
Neither strategy has been tested for targeting of stillbirth specifi cally, but these strategies are 
eff ective against other malaria-related pregnancy outcomes
Measles, mumps, rubella, 
polio, varicella, infl uenza
Maternal vaccination Eff ective for prevention of maternal disease and will probably prevent stillbirths associated 
with maternal infection in pregnancy; the contribution of these maternal infections to stillbirth 
in developing countries is unknown
Worms Deworming Associated with a decrease in stillbirths, but cause and eff ect has not been proven and the 
contribution to the burden of stillbirth is unknown
Table 2: Treatment priorities to reduce infection-related stillbirths
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rates. Potential strategies (table 3) that should be tested are: 
nutritional supplementation with calories or vitamin and 
mineral preparations, or both; reduced exposure of the 
genital tract to bacteria by use of antibiotics or vaginal 
washes with chlorhexidine; and eff ective management of 
both preterm and term premature rupture of mem-
branes.58,59,104 Achievement of high rates of antiviral vaccin-
ation (rubella, rubeola, varicella, polio) should reduce the 
number of associated stillbirths (table 2). Increased under-
stan ding of the association between stillbirth and infec-
tions transmitted by animals and vectors is also required. 
High-income countries
Since the occurrence of infection-related stillbirths is 
reduced in high-income countries, and the range of 
organisms that could be responsible is broad, further 
decreases in occurrence might be diffi  cult. However, 
continued attention to screening and treatment of 
sexually transmitted infections, especially syphilis, and to 
maintenance of high vaccination rates for common 
childhood diseases should keep associated stillbirths to a 
minimum (table 2). Although ACOG and other 
organisations recommend an infl uenza vaccine for 
pregnant women during the infl uenza season, only about 
25% of pregnant women have the vaccine in the USA.
Increased attention to prevention and treatment of 
conditions—eg, Lyme disease—could reduce associated 
stillbirths. Stillbirths linked to toxo plasmosis occur rarely, 
but educational attention to eff orts such as hand washing 
could have a small eff ect. Similarly, a small reduction in 
stillbirths associated with listeriosis might be achieved by 
encouraging pregnant women to avoid soft cheeses and 
various meat and seafood products.
The largest potential area for progress seems to be for 
stillbirths associated with intrauterine bacterial infections 
preceding membrane rupture. Reduction of these 
infections would decrease the frequency of both stillbirths 
and preterm births. Thus far, no eff ective strategies are 
available to reduce such infections, and research to 
develop strategies is crucial.
From a research perspective, the development of 
vaccines for some of the viral causes of stillbirth 
(parvovirus, coxsackie viruses A and B, cytomegalovirus, 
group B streptococcus105,106) should eliminate some 
stillbirths (table 3). However, because of the rarity of 
these deaths in high-income countries, such an approach 
will probably have a small eff ect on stillbirth rates.
Conclusions
High-quality research is crucial to establish causality of 
infection for stillbirths. The best evidence of an 
infectious aetiology for a stillbirth is obtained from a 
careful autopsy and placental examination with 
appropriate serological studies, cultures, and DNA or 
RNA specimens taken to identify infectious organisms. 
New organisms associated with stillbirth should be 
sought.107 However, even if an autopsy is not done, a 
histological study of the placenta, membranes, and 
umbilical cord, with appropriate serological studies, 
cultures, and DNA or RNA specimens, will often provide 
evidence for an infectious aetiology.
One of the most compelling fi ndings related to our 
Review of infection and stillbirths is the many unknowns 
regarding this relation, especially in low-income and 
middle-income countries. For example, we do not know 
whether the high seroprevalences of Lyme disease or 
toxoplasmosis in African settings are associated with 
increased risk of stillbirth, or whether African tick-borne 
relapsing fever is an important cause of stillbirth. Further, 
potential causes of stillbirth such as worm infestations 
have rarely been considered.103 We believe that research 
in several settings in countries of low and middle income, 
using both traditional and the newest molecular and 
culture techniques, should be done to ascertain the full 
extent of the relation between stillbirths and infection. 
Only with this research can we hope to defi ne the reasons 
for the excessive stillbirth burden in such countries and 
develop eff ective reduction strategies.108
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